| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-18 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-16 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-12 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |